FCF Biotech Venture Capital Monitor – USA 01/2022 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 01/2022”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences Venture Capital Monitor – Europe 01/2022 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 01/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life
FCF Automotive Supplier Market Study – 2022 published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF AUTOMOTIVE SUPPLIER MARKET STUDY – 2022”. Based on available data from European automotive suppliers, the FCF AUTOMOTIVE SUPPLIER MARKET STUDY is a detailed
Interest rate turnaround for corporate loans – “This interest rate jump is dramatic” | Wirtschaftswoche 16.02.2022 – Quotes by FCF
Interest rate turnaround for corporate loans – “This interest rate jump is dramatic” | Wirtschaftswoche 16.02.2022 – Quotes by FCF Wirtschaftswoche reports online on February 16, 2022 on the interest rate turnaround for corporate loans
More Deals and higher Volumes in the European Life Sciences Sector
Transaction volume exceeds the EUR 13bn watermark of 2021 Another increase for 2022 can be expected Munich, February 14th, 2022 – The number of investments in the European life sciences sector rose in 2021 up
FCF Biotech Venture Capital Monitor – USA 12/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 12/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Valuation Monitor – Q4 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q4 2021”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
FCF Life Sciences Venture Capital Monitor – Europe 12/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life
6TH ECP FROM FEBRUARY 16 TO 18, 2022 – INTERNATIONAL DECISION-MAKERS MET FOR VIRTUAL EXCHANGE AND FCF APPEARED AS A SPONSOR AGAIN
The 6th ECP took place from February 16 to February 18, 2022, again in an online format and offered the opportunity for international exchange across different time zones. FCF Fox Corporate Finance GmbH appeared again
FCF Biotech Venture Capital Monitor – USA 11/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As